COSADOPGENE PARVEC
UNII 9VH5BU9RHC

Substance Identification & Data

This profile provides standardized clinical and technical data for Cosadopgene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9VH5BU9RHC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3053588-30-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9VH5BU9RHC

CAS Registry Number

3053588-30-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

COSADOPGENE PARVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13830

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cosadopgene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

COSADOPGENE PARVEC

Common Names & Synonyms

COSADOPGENE PARVEC [INN]

RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 2 (RAAV2) VECTOR ENCODING HUMAN GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I (GTP CYCLOHYDROLASE I, GTP-CH-I, GCH, GCH1) UNDER CONTROL OF A CYTOMEGALOVIRUS (CMV) IMMEDIATE-EARLY (IE) ENHANCER/PROMOTER AND A HUMAN .BETA.-GLOBIN INTRON AND TERMINATED BY A HUMAN GROWTH HORMONE POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)

External Clinical & Regulatory Resources

Previous UNII9VH354N8H9

Next UNII9VH76YE3HU